DAFTAR PUSTAKA

Agarwal, R., 2006. Management of Hypertension in Hemodialysis Patients.

Hemodialysis international. International Symposium on Home
Hemodialysis, 10: 241248.

Agarwal, R., Lewis, R., Davis, J.L., dan Becker, B., 2001. Lisinopril Therapy For
Hemodialysis Hypertension: Hemodynamic and Endocrine Responses.
American journal of kidney diseases: the official journal of the National
Kidney Foundation, 38: 12451250.

American Pharmacist Association, 2013, Drug Information Handbook, 22nd ed.,

Lexicomp Inc., Ohio.

Bedendo, J., Giarola, L., Moreira, R., Rossi, R., dan Borelli, S., 2011. Infections
in Patients With Chronic Renal Failure and Kidney Transplant Recipients
in Brazil. Progress in Transplantation, 21: 249253.

Brunner, L. dan Suddarth, D., 2002. Buku Ajar Keperawatan Medical Bedah, 8th
ed. EGC, Jakarta, Indonesia.

Buffet, L., dan Ricchetti, C., 2012. Chronic Kidney Disease and Hypertension: A
Destructive Combination. Diakses pada 20 Juli 2014,
http://www.uspharmacist.com/content/d/featuredarticles/c/35118/

Cappuccio, F.P., Markandu, N.D., Singer, D.R., dan MacGregor, G.A., 1993.
Amlodipine and Lisinopril in Combination For The Treatment of Essential
Hypertension: Efficacy and Predictors of Response. Journal of
Hypertension, 11: 839847.

Caskey, F., Webb, L., Pitcher, D., dan Farrington, K., 2011. Chapter 10 Blood
Pressure Profile of Prevalent Patients Receiving Renal Replacement
Therapy in England, Wales and Northern Ireland in 2010: National And
Centre-Specific Analyses. Nephron Clin Pract, 120: c211.

Cavanaugh, K.L., 2007. Diabetes Management Issues for Patients With Chronic
Kidney Disease. Clinical Diabetes, 25: 9097.

Chen, J., Gul, A., dan Sarnak, M.J., 2006. Unresolved Issues in Dialysis:
Management of Intradialytic Hypertension: The Ongoing Challenge.
Seminars in Dialysis, 19: 141145.

Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo,
J.L., et al., 2003. The Seventh Report of The Joint National Committee on

71

 Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:

The jnc 7 report. JAMA, 289: 25602571.

Chrysant, S.G., Melino, M., Karki, S., Lee, J., dan Heyrman, R., 2008. The
Combination of Olmesartan Medoxomil and Amlodipine Besylate in
Controlling High Blood Pressure: COACH, A Randomized, Double-Blind,
Placebo-Controlled, 8-Week Factorial Efficacy and Safety Study. Clinical
Therapeutics, 30: 587604.

Drug Bank, 2013, Open Data Drug & Drug Target Database, www.drugbank.ca
(diakses pada 30/7/2014).

Fang, W., Oreopoulos, D.., dan Bargman, J.., 2008. Use of ACE Inhibitors or
Angiotensin Receptor Blockers and Survival in Patients On Peritoneal
Dialysis. Oxford University Press on behalf of ERA-EDTA, 17.

Finkelstein, F.O., Story, K., Firanek, C., Mendelssohn, D., Barre, P., Takano, T.,
et al., 2009. Health-Related Quality of Life and Hemoglobin Levels in
Chronic Kidney Disease Patients. Clinical Journal of the American Society
of Nephrology : CJASN, 4: 3338.

Foote, E.F. dan Manley, H.J., 2008. Hemodialysis and Peritoneal Dialysis, dalam:
DiPiro, J., Talbert, R., Yee, G., Matzke, G., Wells, B., Posey, L.M. (Eds.),
Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill Medical,
hal. 793794.

Fox, C.H., Voleti, V., Khan, L.S., Murray, B., dan Vassalotti, J., 2008. A Quick
Guide to Evidence-Based Chronic Kidney Disease Care For The Primary
Care Physician. Postgraduate Medicine, 120: E0106.

Halbesma, N., Brantsma, A.H., Bakker, S.J.L., Jansen, D.F., Stolk, R.P., De
Zeeuw, D., et al., 2008. Gender Differences in Predictors of The Decline
of Renal Function in The General Population. Kidney International, 74:
505512.

Himmelfarb, J. dan Ikizler, T.A., 2010. Hemodialysis. New England Journal of

Medicine, 363: 18331845.

Hobart, J.C., Williams, L.S., Moran, K., dan Thompson, A.J., 2002. Quality of
Life Measurement After Stroke Uses and Abuses of the SF-36. Stroke, 33:
13481356.

Hrl, M.P. dan Hrl, W.H., 2004. Drug therapy for hypertension in hemodialysis
patients. Seminars in dialysis, 17: 288294.

Horl, W.H., 2010. Hypertension in End-Stage Renal Disease: Different Measures

72

 and Their Prognostic Significance. Nephrol Dial Transplant, 25 (10):

3161-3166.

Hudson, J.Q., 2008. Chronic Kidney Disease: Management of Complications,

dalam: DiPiro, J., Talbert, R., Yee, G., Matzke, G., Wells, B., Posey, L.M.
(Eds.), Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill
Medical, hal. 765791.

Hudson, J.. dan Wazny, L.., 2014. Chronic Kidney Disease, dalam: DiPiro, J.,
Talbert, R.L., Yee, G., Wells, B., Posey, L.M. (Eds.), Pharmacotherapy A
Pathophysiologic Approach. McGraw Hill Professional, New York, hal.
633664.

Inrig, J.K., 2010. Antihypertensive Agents in Hemodialysis Patients: A Current

Perspective. Seminars in Dialysis, 23: 290297.

Iseki, K., 2008. Gender Differences in Chronic Kidney Disease. Kidney

International, 74: 415417.

James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Himmelfarb, C.D., Handler,
J., dan et al., 2014. Evidence-Based Guideline For The Management of
High Blood Pressure in Adults: Report From The Panel Members
Appointed to The Eighth Joint National Committee (JNC 8). JAMA, 311:
507520.

Joachim, Lingappa, V.R., dan McPhee, S.J., 2005. Renal Disease, dalam:
Pathophysiology of Disease: An Introduction to Clinical Medicine, Fifth
Edition (LANGE Basic Science). McGraw-Hill Medical, United States of
America, hal. 456481.

KDIGO, 2012. Clinical Practice Guideline for the Evaluation and Management of
Chronic Kidney Disease, 1150.

Kolesnyk, I., Struijk, D.G., dan Dekker, F.., 2010. 'Effect of Angiotensin-
Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in
Patients with Chronic Kidney Disease'. URL:
http://dare.uva.nl/document/161330.

Koomans, H.A., Blankestijn, P.J., dan Joles, J.., 2004. Sympathetic Hyperactivity
in Chronic Renal Failure: A Wake-up Call. Circulation,15: 524537.

Lacourciere, Y., Crikelair, N., Glazer, R.D., Yen, J., dan Calhoun, D.., 2011. 24-
Hour Ambulatory Blood Pressure Control With Triple-Therapy
Amlodipine, Valsartan and Hydrochlorothiazide In Patients With
Moderate to Severe Hypertension. Journal of Human Hypertension, 25:
615622.

73

Malliara, M., 2007. The management of hypertension in hemodialysis and CAPD

patients. Hippokratia, 11: 171174.

Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bhm, M., et
al., 2013. ESH/ESC Guidelines For The Management of Arterial
Hypertension: The Task Force For The Management of Arterial
Hypertension of The European Society of Hypertension (ESH) and of The
European Society of Cardiology (ESC). European Heart Journal, 34:
21592219.

Mitra, S., Chandna, S.., dan Farrington, K., 1999. What is Hypertension in
Chronic Hemodyalisis?The Role of Interdialytic Blood Pressure
Monitoring. Nephrology Dialysis Transplantation, 14: 29152921.

Nafrialdi, 2007. Antihipertensi, dalam: Farmakologi Dan Terapi. Balai Penerbit

FKUI, Jakarta, hal. 341360.

National Kidney Foundation, 2005. NKF KDOQI Guidelines. URL:

https://www.kidney.org/professionals/kdoqi/guidelines_cvd/guide12.htm
(diakses tanggal 18/2/2014).

National Kidney Foundation, 2013. The National Kidney Foundation: Kidney

Disease About Chronic Kidney Disease. URL:
https://www.kidney.org/kidneydisease/aboutckd.cfm (diakses tanggal
18/2/2014).

Neff, M.S., Kim, K.E., Persoff, M., Onesti, G., dan Swartz, C., 1971.
Hemodynamics of Uremic Anemia. Circulation, 43: 876883.

NICE guideline, 2010. Anaemia management in people with chronic kidney

disease (partial update). URL:
http://www.nice.org.uk/guidance/cg114/resources/anaemia-management-
in-chronic-kidney-disease-update-consultation-nice-short-version2.

Notopoero, P.., 2014. Eritropoitin Fisiologi, Aspek Klinik, dan Laboratorik. URL:
http://journal.unair.ac.id/filerPDF/PDFVol2014-01-06.pdf.

OCallaghan, C. dan Brenner, B.M., 2000. The Kidney at a Glance, 1 edition. ed.
Wiley-Blackwell.

Pranawa, Yogiantoro, M., Irwandi, C., Santoso, D., Mardiana, N., Thaha, M.,
dkk., 2007. Penyakit Ginjal Kronis, dalam: Buku Ajar Ilmu Penyakit
Dalam. Airlangga University Press, Fakultas Kedokteran Universitas
Airlangga - RSP Dr. Soetomo Surabaya, hal. 221229.

74

Prasad, G.R., Ruzicka, M., Burns, K.D., Tobe, S.W., dan Lebel, M., 2009.
Hypertension in dialysis and kidney transplant patients. The Canadian
Journal of Cardiology, 25: 309314.

Prichard, S.., 2000. Comorbidities and Their Impact on Outcome in Patients With
End-Stage Renal Disease. Kidney International, 57: S100S104.

Qin, X., Huo, Y., Langman, C.B., Hou, F., Chen, Y., Matossian, D., et al., 2011.
Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced
Chronic Kidney Disease: A Meta-Analysis. Clinical journal of the
American Society of Nephrology: CJASN, 6: 482488.

Rahman, M. dan Griffin, V., 2004. Patterns of Antihypertensive Medication Use

in Hemodialysis Patients. American Journal of Health-System Pharmacy:
AJHP: Official Journal of The American Society of Health-System
Pharmacists, 61: 14731478.

Ravera, M., Re, M., Deferrari, L., Vettoretti, S., dan Deferrari, G., 2006.
Importance of Blood Pressure Control in Chronic Kidney Disease. Journal
of the American Society of Nephrology, 17: S98S103.

Saseen, J.J. dan MacLaughlin, E.J., 2008. Hypertension, dalam: DiPiro, J.,
Talbert, R., Yee, G., Matzke, G., Wells, B., Posey, L.M. (Eds.),
Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill Medical,
hal. 139172.

Schonder, K.S., 2007. Chronic and End-Stage Renal Disease, dalam: Chisholm-
Burns, M., Wells, B., Schwinghammer, T., Malone, P., Kolesar, J.,
Rotschafer, J., dkk. (Eds.), Pharmacotherapy Principles & Practice.
McGraw-Hill Medical, New York, hal. 373402.

Schwenger, V., dan Ritz, E., 1998. Audit of Antihypertensive Treatment in

Patients with Renal Failure. Nephrol Dial Transplant, 13: 3091-3095

Septiwi, C., 2010. 'Hubungan Antara Adekuasi Hemodialisis Dengan Kualitas

Hidup Pasien Hemodialisis di Unit Hemodialisis RS Prof. Dr. Margono
Soekarjo Purwokerto', Tesis, M.I.Kep, Universitas Indonesia, Depok.

Shimada, H., Kitamura, K., Anraku, M., Miyoshi, T., Adachi, M., Tuyen, D.G., et
al., 2005. Effect of Telmisartan on Ambulatory Blood Pressure
Monitoring, Plasma Brain Natriuretic Peptide, and Oxidative Status of
Serum Albumin in Hemodialysis Patients. Hypertension Research, 28:
987994.

Sica, D., 2004. Calcium Channel Blockers and The Kidney. Clinical Cornerstone,
6: 3952.

75

SIGN Guideline, 2008. Diagnosis and Management of Chronic Kidney Disease.

URL: http://www.sign.ac.uk/pdf/sign103.pdf.

Suwitra, K., 2006. Penyakit Ginjal Kronik, dalam: Buku Ajar Ilmu Penyakit
Dalam. Pusat Penerbitan Departemen Ilmu Penyakit Dalam FKUI, Jakarta,
hal. 581.

Taylor, A., dan Ragbir, S., 2012. Three in One: Safety, Efficacy, and Patient
Acceptability of Triple Fixed-Dose Combination Medicine in the
Management of Hypertension. Dove Medical Press, 6: 555-563.

Tepel, M., Hopfenmueller, W., Scholze, A., Maier, A., dan Zidek, W., 2008.
Effect of Amlodipine on Cardiovascular Events in Hypertensive
Haemodialysis Patients. Nephrology Dialysis Transplantation, 23: 3605
3612.

Tonelli, M., Pannu, N., dan Manns, B., 2010. Oral Phosphate Binders in Patients
with Kidney Failure. New England Journal of Medicine, 362: 13121324.

United States Renal Data System, 2012. ESRD Incidence, Prevalence, Patient
Characteristics and Modalities. URL:
http://www.usrds.org/2012/view/v2_01.aspx (diakses tanggal 11/8/2014).

USRDS, 2007. Annual Data Report: Atlas of End-Stage Renal Disease in the
United States. National Institutes of Health, National of Diabetes and
Digestive and Kidney Diabetes, Bethesda, MD. URL:
http://www.usrds.org/atlas07.aspx (diakses tanggal 11/8/2014).

Volpe, M. dan Tocci, G., 2012. Rationale For Triple Fixed-Dose Combination
Therapy With An Angiotensin II Receptor Blocker, A Calcium Channel
Blocker, and A Thiazide Diuretic. Vascular Health and Risk Management,
8: 371380.

Wilcox, C.S., 2002. New Insights into Diuretic Use in Patients with Chronic
Renal Disease. Journal of the American Society of Nephrology, 13: 798
805.

Wu, H.Y., Huang, J.W., Lin, H.J., Liao, W.C., Peng, Y.S., Hung, K.Y., et al.,
2013. Comparative Effectiveness of Renin-Angiotensin System Blockers
and Other Antihypertensive Drugs in Patients With Diabetes: Systematic
Review and Bayesian Network Meta-Analysis. BMJ : British Medical
Journal, 347: f6008

76